For HCPs, Request Your Two-week Kardia 12L Trial Today | Inquire Now

AliveCor Logo

Our Technology

Our Devices

Kardia 12L

New

KardiaMobile 6L
K1000 (Instant QT)
KardiaMobile

Our Software

KardiaPro
KardiaStation
KardiaComplete
API & SDK Solutions
RPM & CCM Solutions
Our AI

Our Solutions

For Physicians & Providers
For Health Systems & Clinics

For Life Sciences Industry

Clinical Trials
Patient Engagement
For Employers
For Emergency Medical Services
For Veterans Affairs
For Payors
For Consumers

About

Mission
Leadership
The Human Component Film
Newsroom

Resources

Clinical Evidence

Publications
Case Studies

Technical Resources

Kardia 12L
KardiaMobile 6L
KardiaPro
KardiaStation
AliveCor K1000
Reimbursement

Industry Insights

Our Blogs
Testimonials
Learning Library

Events

Webinars
Upcoming Events
Past Events
(855) 338-8800
AliveCor Logo
AliveCor Logo
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
    • (855) 338-8800
    • Mission
    • Careers
    • Research
    • Newsroom
    • FAQs
    • User Manuals
    • Compatibility
    • Shipping
    • (855) 338-8800
    • KardiaMobile Card
    • KardiaMobile 6L
    • KardiaMobile
    • KardiaCare
    • International
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • Privacy Policy
  • Security
  • Telehealth Informed Consent
  • Terms
  • Accessibility

©2024 AliveCor, Inc. All Rights Reserved. Patents www.alivecor.com/patents. AliveCor and Kardia are trademarks of AliveCor, Inc. in the United States and other countries. Apple is a trademark of Apple, Inc. registered in the U.S. and other countries. App Store is a service mark of Apple, Inc. Android is a trademark of Google Inc. Google Play is a trademark of Google Inc.

Go Back
Olympic Icon Mark Spitz Partners with AliveCor To Build Awareness Around Heart Health
LOS ANGELES, CA, USA, September 10, 2019

Mark Spitz aims to bring the realities of heart health into focus no matter what physical shape one might be in.

LOS ANGELES, Sept. 10, 2019 /PRNewswire/ – Many remember 9-time Gold Medalist, Mark Spitz, as one of the greatest Olympic athletes of all time. Now Spitz has announced he's been diagnosed with Atrial Fibrillation (AFib) which affects more than 2.7 million Americans and is defined as a quivering or irregular heartbeat that can lead to blood clots, heart failure, and a five-fold increased risk for stroke.

Spitz wants to use his story to shed light onto the fact that this could happen to anyone, even an Olympic athlete. To increase awareness around the seriousness of AFib and heart health in general, Spitz has partnered with industry leader AliveCor , maker of KardiaMobile, the FDA-cleared personal electrocardiogram (ECG), to ensure people have access to an affordable, accurate ECG that can be used anytime, anywhere.

Years after his record setting performances in the pool, Spitz has maintained a commitment to physical health throughout his life as a businessman, celebrity spokesperson, husband and father.

“When I was diagnosed with AFib, my first thought was, ‘how could this happen to me?’ The life I thought I had changed forever,” said Spitz. “Together with AliveCor, our goal is to create a broader discussion around heart health and inform others of this device that gives me peace of mind despite my diagnosis.”

AliveCor was named the #1 artificial intelligence company on Fast Company's Top 50 Most Innovative Companies and its FDA-cleared KardiaMobile product is the most clinically validated mobile ECG solution in the world. This device is not only for people suffering from AFib; it also detects fast and slow heart rates (Tachycardia, Bradycardia) and allows people to monitor for Normal heart rhythm.

“Mark Spitz's diagnosis illustrates the widespread impact that heart health has across the United States. Mark is an exemplar of his generation and has maintained a healthy lifestyle beyond his Olympic years. As our population continues to age, he is a role model for confident and insightful health management,” said Priya Abani, CEO of AliveCor.

Throughout this new partnership, Spitz will appear on television and social media campaigns in addition to sharing video and blog updates on his AliveCor web page, markspitz.alivecor.com , to create an educational online forum for heart health discussion.

For media inquiries, please contact Matt Uberseder of Limitless Creative Group at matt@limitlesscreativegroup.com or (336) 816-0976.

For more information about AliveCor, please visit www.alivecor.com .

SOURCE Mark Spitz

Let's transform cardiovascular care together

If you are an employer or payer looking for a comprehensive heart health enterprise solution, contact us.